Suppr超能文献

结直肠癌肝转移的肿瘤微环境与组织学生长模式

The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns.

作者信息

Garcia-Vicién Gemma, Mezheyeuski Artur, Bañuls María, Ruiz-Roig Núria, Molleví David G

机构信息

Tumoral and Stromal Chemoresistance Group, Molecular Mechanisms and Experimental Therapy in Oncology Program (ONCOBELL), Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, 08908 L'Hospitalet de Llobregat, Spain.

Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, 08908 L'Hospitalet de Llobregat, Spain.

出版信息

Int J Mol Sci. 2021 Feb 3;22(4):1544. doi: 10.3390/ijms22041544.

Abstract

Colorectal carcinoma (CRC) is the third most common cancer. Likewise, it is a disease that has a long survival if it is prematurely detected. However, more than 50% of patients will develop metastases, mainly in the liver (LM-CRC), throughout the evolution of their disease, which accounts for most CRC-related deaths. Treatment it is certainly a controversial issue, since it has not been shown to increase overall survival in the adjuvant setting, although it does improve disease free survival (DFS). Moreover, current chemotherapy combinations are administered based on data extrapolated from primary tumors (PT), not considering that LM-CRC present a very particular tumor microenvironment that can radically condition the effectiveness of treatments designed for a PT. The liver has a particular histology and microenvironment that can determine tumor growth and response to treatments: double blood supply, vascularization through fenestrated sinusoids and the presence of different mesenchymal cell types, among other particularities. Likewise, the liver presents a peculiar immune response against tumor cells, a fact that correlates with the poor response to immunotherapy. All these aspects will be addressed in this review, putting them in the context of the histological growth patterns of LM-CRC, a particular pathologic feature with both prognostic and predictive repercussions.

摘要

结直肠癌(CRC)是第三大常见癌症。同样,如果能早期发现,这是一种生存期较长的疾病。然而,超过50%的患者在疾病进展过程中会发生转移,主要转移至肝脏(肝转移结直肠癌,LM-CRC),这是大多数CRC相关死亡的原因。其治疗无疑是一个有争议的问题,因为在辅助治疗中尚未证明其能提高总生存期,尽管它确实能改善无病生存期(DFS)。此外,目前的化疗方案是根据从原发性肿瘤(PT)推断的数据进行给药的,没有考虑到LM-CRC具有非常特殊的肿瘤微环境,这可能从根本上影响针对PT设计的治疗的有效性。肝脏具有特殊的组织学和微环境,可决定肿瘤的生长和对治疗的反应:双重血液供应、通过有孔窦状隙的血管化以及存在不同的间充质细胞类型等。同样,肝脏对肿瘤细胞呈现出特殊的免疫反应,这一事实与对免疫治疗的不良反应相关。本综述将探讨所有这些方面,并将它们置于LM-CRC的组织学生长模式背景下,这是一种具有预后和预测影响的特殊病理特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f71a/7913731/568f4c756116/ijms-22-01544-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验